文章基本信息

标题：Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
本地全文：下载
作者：Feng Wang ; Qian Yin ; Liang Chen 等
期刊名称：Proceedings of the National Academy of Sciences
印刷版ISSN：0027-8424
电子版ISSN：1091-6490
出版年度：2018
卷号：115
期号：1
页码：157-161
DOI：10.1073/pnas.1712901115
语种：English
出版社：The National Academy of Sciences of the United States of America
摘要：Antibodies that attenuate immune tolerance have been used to effectively treat cancer, but they can also trigger severe autoimmunity. To investigate this, we combined anti–CTLA-4 treatment with a standard colitis model to give mice a more severe form of the disease. Pretreatment with an antibiotic, vancomycin, provoked an even more severe, largely fatal form, suggesting that a Gram-positive component of the microbiota had a mitigating effect. We then found that a commonly used probiotic, Bifidobacterium , could largely rescue the mice from immunopathology without an apparent effect on antitumor immunity, and this effect may be dependent on regulatory T cells.
关键词：probiotics ; Bifidobacterium ; CTLA-4 ; immune checkpoint blockade ; intestinal immunopathology